Similar articles

• Comparison of the therapeutic effects of adriamycin alone versus adriamycin plus vincristine versus adriamycin plus cyclophosphamide in the treatment of advanced carcinoma of the cervix.

  Wallace HJ Jr, Hreshchyshyn MM, Wilbanks GD, Boronow RC, Fowler WC Jr, Blessing JA. Wallace HJ Jr, et al. Cancer Treat Rep. 1978 Oct;62(10):1435-41. Cancer Treat Rep. 1978. PMID: 709549 Clinical Trial. No abstract available.
• Adriamycin versus adriamycin and bleomycin in advanced epidermoid carcinoma of the cervix.

  Greenberg BR, Kardinal CG, Pajak TF, Bateman JR. Greenberg BR, et al. Cancer Treat Rep. 1977 Oct;61(7):1383-4. Cancer Treat Rep. 1977. PMID: 73417 Clinical Trial. No abstract available.
• Phase II randomized study of doxorubicin, vincristine, and 5-FU versus cyclophosphamide in advanced squamous cell carcinoma of the cervix.

  Omura GA, Vélez-García E, Birch R. Omura GA, et al. Cancer Treat Rep. 1981 Sep-Oct;65(9-10):901-3. Cancer Treat Rep. 1981. PMID: 7196801 Clinical Trial.
• The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.

  Thigpen T, Vance RB, Khansur T. Thigpen T, et al. Semin Oncol. 1995 Oct;22(5 Suppl 12):67-75. Semin Oncol. 1995. PMID: 7481864 Review.
• Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma.

  Thigpen T, Vance RB, Balducci L, Blessing J. Thigpen T, et al. Cancer. 1981 Jul 15;48(2 Suppl):658-65. doi: 10.1002/1097-0142(19810715)48:1+<658::aid-cncr2820481334>3.0.co;2-r. Cancer. 1981. PMID: 7023669 Review. No abstract available.